|
1
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johannesen TB, Langmark F and Lote K:
Cause of death and long-term survival in patients with
neuro-epithelial brain tumours: a population-based study. Eur J
Cancer. 39:2355–2363. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yeo CW, Ng FS, Chai C, Tan JM, Koh GR,
Chong YK, Koh LW, Foong CS, Sandanaraj E, Holbrook JD, Ang BT,
Takahashi R, Tang C and Lim KL: Parkin pathway activation mitigates
glioma cell proliferation and predicts patient survival. Cancer
Res. 72:2543–2553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan
X, Gong Y, Yin B, Liu W, Qiang B, Zhao J, Yuan J and Peng X:
MicroRNA-128 inhibits glioma cells proliferation by targeting
transcription factor E2F3a. J Mol Med. 87:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Komotar RJ, Otten ML, Moise G and Connolly
ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma - a critical review. Clin Med Oncol. 2:421–422.
2008.PubMed/NCBI
|
|
6
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A,
Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uren AG, Pakusch M, Hawkins CJ, Puls KL
and Vaux DL: Cloning and expression of apoptosis inhibitory protein
homologs that function to inhibit apoptosis and/or bind tumor
necrosis factor receptor-associated factors. Proc Natl Acad Sci
USA. 93:4974–4978. 1996. View Article : Google Scholar
|
|
8
|
Takahashi R, Deveraux Q, Tamm I, Welsh K,
Assa-Munt N, Salvesen GS and Reed JC: A single BIR domain of XIAP
sufficient for inhibiting caspases. J Biol Chem. 273:7787–7790.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reuter S, Prasad S, Phromnoi K, Kannappan
R, Yadav VR and Aggarwal BB: Embelin suppresses osteoclastogenesis
induced by receptor activator of NF-κB ligand and tumor cells in
vitro through inhibition of the NF-κB cell signaling pathway. Mol
Cancer Res. 8:1425–1436. 2010.PubMed/NCBI
|
|
10
|
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita
Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME,
Yang D and Wang S: Discovery of embelin as a cell-permeable,
small-molecular weight inhibitor of XIAP through structure-based
computational screening of a traditional herbal medicine
three-dimensional structure database. J Med Chem. 47:2430–2440.
2004. View Article : Google Scholar
|
|
11
|
Kim SW, Kim SM, Bae H, Nam D, Lee JH, Lee
SG, Shim BS, Kim SH and Ahn KS, Choi SH, Sethi G and Ahn KS:
Embelin inhibits growth and induces apoptosis through the
suppression of Akt/mTOR/S6K1 signaling cascades. Prostate.
73:296–305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Danquah M, Li F, Duke CB III, Miller DD
and Mahato RI: Micellar delivery of bicalutamide and embelin for
treating prostate cancer. Pharm Res. 26:2081–2092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mori T, Doi R, Kida A, Nagai K, Kami K,
Ito D, Toyoda E, Kawaguchi Y and Uemoto S: Effect of the XIAP
inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer
cells. J Surg Res. 142:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aird KM, Ding X, Baras A, Wei J, Morse MA,
Clay T, Lyerly HK and Devi GR: Trastuzumab signaling in
ErbB2-overexpressing inflammatory breast cancer correlates with
X-linked inhibitor of apoptosis protein expression. Mol Cancer
Ther. 7:38–47. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma
J, Zou B, Gu Q, Wang J, Pang R, Lan HY and Wong BC: Peroxisome
proliferator-activated receptor-gamma contributes to the inhibitory
effects of Embelin on colon carcinogenesis. Cancer Res.
69:4776–4783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong J, Kong X, Zhang H, Yu C, Xu Y, Kang
J, Yu H, Yi H, Yang X and Sun L: Inhibition of CLIC4 enhances
autophagy and triggers mitochondrial and ER stress-induced
apoptosis in human glioma U251 cells under starvation. PLoS One.
7:e393782012. View Article : Google Scholar
|
|
17
|
Zhou J, Cheng G, Cheng G, Tang HF and
Zhang X: Novaeguinoside II inhibits cell proliferation and induces
apoptosis of human brain glioblastoma U87MG cells through the
mitochondrial pathway. Brain Res. 1372:22–28. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ordys BB, Launay S, Deighton RF, McCulloch
J and Whittle IR: The role of mitochondria in glioma
pathophysiology. Mol Neurobiol. 42:64–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du J, Tang B, Wang J, Sui H, Jin X, Wang L
and Wang Z: Antiproliferative effect of alpinetin in BxPC-3
pancreatic cancer cells. Int J Mol Med. 29:607–612. 2012.PubMed/NCBI
|
|
20
|
Zhang ZF, Guo Y, Zhang JB and Wei XH:
Induction of apoptosis by chelerythrine chloride through
mitochondrial pathway and Bcl-2 family proteins in human hepatoma
SMMC-7721 cell. Arch Pharm Res. 34:791–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang B, Zhang Y, Liang R, Yuan P, Du J,
Wang H and Wang L: Activation of the δ-opioid receptor inhibits
serum deprivation-induced apoptosis of human liver cells via the
activation of PKC and the mitochondrial pathway. Int J Mol Med.
28:1077–1085. 2011.
|
|
22
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiarugi P and Giannoni E: Anoikis: a
necessary death program for anchorage-dependent cells. Biochem
Pharmacol. 76:1352–1364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heo JY, Kim HJ, Kim SM, Park KR, Park SY,
Kim SW, Nam D, Jang HJ, Lee SG and Ahn KS, Kim SH, Shim BS, Choi SH
and Ahn KS: Embelin suppresses STAT3 signaling, proliferation, and
survival of multiple myeloma via the protein tyrosine phosphatase
PTEN. Cancer Lett. 308:71–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu R, Zhu K, Li Y, Yao K, Zhang R, Wang H,
Yang W and Liu Z: Embelin induces apoptosis through down-regulation
of XIAP in human leukemia cells. Med Oncol. 28:1584–1588. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allensworth JL, Aird KM, Aldrich AJ,
Batinic-Haberle I and Devi GR: XIAP inhibition and generation of
reactive oxygen species enhances TRAIL sensitivity in inflammatory
breast cancer cells. Mol Cancer Ther. 11:1518–1527. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Joy B, Sivadasan R, Abraham TE, John M,
Sobhan PK and Seervi M; TRS. Lysosomal destabilization and
cathepsin B contributes for cytochrome c release and caspase
activation in embelin-induced apoptosis. Mol Carcinog. 49:324–336.
2010.PubMed/NCBI
|
|
28
|
Von Haefen C, Wendt J, Semini G, Sifringer
M, Belka C, Radetzki S, Reutter W, Daniel PT and Danker K:
Synthetic glycosidated phospholipids induce apoptosis through
activation of FADD, caspase-8 and the mitochondrial death pathway.
Apoptosis. 16:636–651. 2011.PubMed/NCBI
|
|
29
|
Burlacu A: Regulation of apoptosis by
Bcl-2 family proteins. J Cell Mol Med. 7:249–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saito M, Korsmeyer SJ and Schlesinger PH:
BAX-dependent transport of cytochrome c reconstituted in pure
liposomes. Nat Cell Biol. 2:553–555. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsuyama S, Llopis J, Deveraux QL, Tsien
RY and Reed JC: Changes in intramitochondrial and cytosolic pH:
early events that modulate caspase activation during apoptosis. Nat
Cell Biol. 2:318–325. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fiandalo MV and Kyprianou N: Caspase
control: protagonists of cancer cell apoptosis. Exp Oncol.
34:165–175. 2012.PubMed/NCBI
|
|
33
|
Wen X, Lin ZQ, Liu B and Wei YQ:
Caspase-mediated programmed cell death pathways as potential
therapeutic targets in cancer. Cell Prolif. 45:217–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
